Acadia Healthcare's (ACHC) stock plummeted by a staggering 22.39% in pre-market trading on Friday, following the release of disappointing fourth-quarter 2024 financial results and a lacklustre full-year 2025 guidance.
The leading provider of behavioral healthcare services reported revenue of $774.2 million for the fourth quarter, missing the consensus estimate of $779 million. Additionally, the company's adjusted EBITDA of $153.1 million fell short of the expected $171.4 million, despite posting a net income of $33.5 million for the quarter.
Looking ahead, Acadia's full-year 2025 guidance further dampened investor sentiment. The company forecasted revenue in the range of $3.3 billion to $3.4 billion and adjusted EBITDA between $675 million and $725 million, both falling below analysts' expectations. Acadia also anticipated capital expenditures ranging from $525 million to $575 million as it continues to invest in expanding its psychiatric bed capacity to meet the growing demand for mental health services.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。